Molecular profiling of individual tumor cells by hyperspectral microscopic imaging.

[1]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[2]  Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[4]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[5]  Thomas D. Nielsen,et al.  Hyperspectral imaging: a novel approach for microscopic analysis. , 2001, Cytometry.

[6]  M.L. Huebschman,et al.  Characteristics and capabilities of the hyperspectral imaging microscope , 2002, IEEE Engineering in Medicine and Biology Magazine.

[7]  Simon Goldbard,et al.  High-throughput cell analysis using multiplexed array technologies. , 2002, Drug discovery today.

[8]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[9]  J. Kutok,et al.  MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. , 2003, Cancer cell.

[10]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Tanja Fehm,et al.  HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Loibl,et al.  Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. , 2004, Neoplasia.

[13]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[14]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[15]  N. Lane,et al.  Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. , 2005, Cytotherapy.

[16]  T. Fehm,et al.  Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients , 2006, Breast Cancer Research and Treatment.

[17]  E. Petricoin,et al.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[19]  J. Mendelsohn,et al.  Circulating tumor cells in breast cancer: Advanced tools for “tailored” therapy? , 2006, Proceedings of the National Academy of Sciences.

[20]  A. Giuliano,et al.  Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.

[21]  M. Delorenzi,et al.  Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Sanjay Shete,et al.  uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues , 2006, Proceedings of the National Academy of Sciences.

[23]  D. Mavroudis,et al.  Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. , 2006, Clinical biochemistry.

[24]  K. Pantel,et al.  Recent translational research: circulating tumor cells in breast cancer patients , 2006, Breast Cancer Research.

[25]  I. Hedenfalk,et al.  High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer , 2006, Breast Cancer Research.

[26]  J. Horiguchi,et al.  The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer , 2007, Breast cancer.

[27]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[28]  T. Fehm,et al.  Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status , 2007, Breast Cancer Research.

[29]  Sabine Riethdorf,et al.  Circulating Tumor Cells and Bone Marrow Micrometastasis , 2008, Clinical Cancer Research.

[30]  J. Rüschoff,et al.  Proficiency testing of immunohistochemical biomarker assays in breast cancer , 2008, Virchows Archiv.

[31]  M. Loda,et al.  Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer , 2009, Clinical Cancer Research.

[32]  Kevin P. Rosenblatt,et al.  Hyperspectral microscopy imaging to analyze pathology samples with multicolors reduces time and cost , 2009, BiOS.

[33]  Annibale Biggeri,et al.  Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients , 2009, Breast Cancer Research and Treatment.

[34]  X. Ye,et al.  Rnai-mediated Downregulation of Upar Synergizes with Targeting of Her2 through the Erk Pathway in Breast Cancer Cells , 2022 .

[35]  Jeffrey S. Morris,et al.  Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study , 2010, Clinical Cancer Research.

[36]  S. Loibl,et al.  Silencing of the HER 2 / neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER 2 / neu – Overexpressing Breast Cancer Cells 1 , 2014 .